跳至主要内容
临床试验/IRCT20190522043672N2
IRCT20190522043672N2招募中2 期

Preventive effect of pentoxifylline in Acute Respiratory Distress Syndrome susceptible children

Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 month 至 18 years(—)
性别
All

入选标准

  • •All patients at risk for ARDS who have lips=4 based on lung injury prediction score (lips) and do not complete the ARDS diagnosis criteria

排除标准

  • •Acute prenatal hypoxemia such as premature infant-related lung disease, prenatal lung injury (such as Meconium Aspiration Syndrome, pneumonia, and sepsis occurring during childbirth) are excluded.
  • •A disease that inevitably leads to death and is contrary to life
  • •Children with adrenal insufficiency
  • •Inflammation of blood vessels
  • •Patients with intolerance to methylxanthine and pentoxifylline

研究者

相似试验